论文信息 - A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer - 字舞流文

A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

F. Janku | D. Rasco | A. Patnaik | D. Hong | M. Gordon | S. Fu | Melinda D Willard | Wei Zhang | S. Hynes | A. Lin | F. Tsai | Kyri Papadopoulous | S. Beeram | S. Gundala | M. D. Willard